Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.

Sosman JA, Kim KB, Schuchter L, Gonzalez R, Pavlick AC, Weber JS, McArthur GA, Hutson TE, Moschos SJ, Flaherty KT, Hersey P, Kefford R, Lawrence D, Puzanov I, Lewis KD, Amaravadi RK, Chmielowski B, Lawrence HJ, Shyr Y, Ye F, Li J, Nolop KB, Lee RJ, Joe AK, Ribas A
N Engl J Med. 2012 366 (8): 707-14

PMID: 22356324 · PMCID: PMC3724515 · DOI:10.1056/NEJMoa1112302

MeSH Terms (16)

Adult Aged Disease Progression Female Humans Indoles Kaplan-Meier Estimate Male Melanoma Middle Aged Mutation Neoplasm Metastasis Proto-Oncogene Proteins B-raf Sulfonamides Treatment Outcome Vemurafenib

Connections (3)

This publication is referenced by other Labnodes entities:

Links